Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Today's Research Reports on Emblem, OrganiGram, Oncolytics Biotech and Aptose Biosciences

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/11/2018 | 02:08pm CEST

NEW YORK, NY / ACCESSWIRE / July 11, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Emblem Corp.
https://rdinvesting.com/news/?ticker=EMC.V

OrganiGram Holdings Inc.
https://rdinvesting.com/news/?ticker=OGI.V

Oncolytics Biotech Inc.
https://rdinvesting.com/news/?ticker=ONC.TO

Aptose Biosciences Inc.
https://rdinvesting.com/news/?ticker=APS.TO

Emblem's stock had no change Tuesday, to close the day at $1.28. The stock recorded a trading volume of 124,012 shares, which was below its three months average volume of 380,350 shares. In the last year, Emblem's shares have traded in a range of 1.15 - 26.32. The stock is currently trading 95.14% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $1.43 is below its 200-day moving average of $1.60. Shares of Emblem have fallen approximately 43.86 percent year-to-date.

Access RDI's Emblem Corp. Research Report at:
https://rdinvesting.com/news/?ticker=EMC.V

On Tuesday, shares of OrganiGram recorded a trading volume of 567,459 shares, which was below the three months average volume of 766,884 shares. The stock ended the day 0.59% lower at 5.04. The share price has gained 147.06% from its 52 week low with a 52 week trading range of 2.04 - 5.93. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.25 is greater than its 200-day moving average of $4.50. Shares of OrganiGram have gained approximately 22.93 percent year-to-date.

Access RDI's OrganiGram Holdings Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OGI.V

Oncolytics Biotech's stock moved 4.74% lower Tuesday, to close the day at $7.44. The stock recorded a trading volume of 12,295 shares, which was below its three months average volume of 158,931 shares. In the last year, Oncolytics Biotech's shares have traded in a range of 4.48 - 10.67. The share price has gained 66.07% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $8.48 is greater than its 200-day moving average of $7.41. Shares of Oncolytics Biotech have gained approximately 10.03 percent year-to-date.

Access RDI's Oncolytics Biotech Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ONC.TO

On Tuesday, shares of Aptose Biosciences recorded a trading volume of 31,579 shares, which was below the three months average volume of 38,858 shares. The stock ended the day 2.60% lower at 4.49. The share price has gained 173.78% from its 52 week low with a 52 week trading range of 1.64 - 5.97. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.02 is greater than its 200-day moving average of $4.16. Shares of Aptose Biosciences have gained approximately 61.51 percent year-to-date.

Access RDI's Aptose Biosciences Inc. Research Report at:
https://rdinvesting.com/news/?ticker=APS.TO

Our Actionable Research on Emblem Corp. (TSX-V: EMC.V) and OrganiGram Holdings Inc. (TSX-V: OGI.V) and Oncolytics Biotech Inc. (TSX: ONC.TO) and Aptose Biosciences Inc. (TSX: APS.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

Stocks mentioned in the article
ChangeLast1st jan.
APTOSE BIOSCIENCES INC 1.20% 3.37 Delayed Quote.19.78%
EMBLEM CORP --End-of-day quote.
ONCOLYTICS BIOTECH INC. -0.71% 5.63 Delayed Quote.-18.90%
ORGANIGRAM HOLDINGS INC --End-of-day quote.

© Accesswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
03:52pLegal Notices
AQ
03:51pINDIA GLOBALIZATION CAPITAL : Data Projects Canada's First Year Legal Cannabis Sales to Eclipse USD 4 Billion
PR
03:51pAT&T : Thinking about buying stock in Corbus Pharma, Cronos Group, Micron, New Age Beverages Co. or AT&T?
PR
03:51pTHE MARKETING GROUP PLC : Board Changes
AQ
03:50pJERASH US : Mobile Children's Museum will visit Irbid, Jerash for upcoming tour
AQ
03:49pCENTRICA : Residential installs begin at Cornwall's Local Energy Market
PU
03:49pSBERBANK HOLDS BUSINESS BREAKFAST RUSSIAN AGRICULTURE 2.0 : Focusing on Exports
PU
03:45pENGIE : Delays Restart Date of Two Nuclear Units, Confirms 2018 Targets
DJ
03:44pE COMMODITIES : Announcements and Notices - On-market Repurchase of Shares
PU
03:44pIJM BHD : Changes in Substantial Shareholdings (EPF)
PU
Latest news "Companies"
Advertisement